Institutional
Tri Locum Partners LP
CIK 0001826434
$712.5M
Reported AUM
17
Positions
Q1 2026
Period
2026-05-18
Filed
The Brief · Tri Locum Partners LP · Q1 2026
AI · grounded in 13F
Tri Locum Partners LP exited its position in DHR for a reduction of $79.4M. The fund established new positions in ISRG for $70.6M, TMO for $65.1M, and VRTX for $57.7M. Other notable activity includes closing positions in BSX and IONS, while increasing its stake in DEXCOM INC by 65.6%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | JNJ | JOHNSON & JOHNSON | $101.3M | 14.22% | -188,640 | -31.3% |
| 2 | ISRG | INTUITIVE SURGICAL INC | $70.6M | 9.91% | +153,250 | NEW |
| 3 | TMO | THERMO FISHER SCIENTIFIC INC | $65.1M | 9.13% | +132,413 | NEW |
| 4 | ASNDUSD | ASCENDIS PHARMA A/S | $58.4M | 8.20% | -9,683 | -3.7% |
| 5 | VRTX | VERTEX PHARMACEUTICALS INC | $57.7M | 8.10% | +129,314 | NEW |
| 6 | LLY | ELI LILLY & CO | $56.8M | 7.98% | -1,489 | -2.4% |
| 7 | MDGL | MADRIGAL PHARMACEUTICALS INC | $54.1M | 7.59% | +17,265 | +20.1% |
| 8 | DXCM | DEXCOM INC | $43.8M | 6.15% | +276,558 | +65.6% |
| 9 | UTHR | UNITED THERAPEUTICS CORP DEL | $41.7M | 5.86% | -50,551 | -41.8% |
| 10 | NUVL | NUVALENT INC | $31.6M | 4.44% | +1,135 | +0.4% |
| 11 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $30.8M | 4.32% | -414,857 | -28.9% |
| 12 | JAZZ | JAZZ PHARMACEUTICALS PLC | $30.0M | 4.21% | +158,663 | NEW |
| 13 | ARGX | ARGENX SE | $23.1M | 3.24% | -6,018 | -16.0% |
| 14 | TARS | TARSUS PHARMACEUTICALS INC | $17.7M | 2.49% | +252,588 | NEW |
| 15 | DNTH | DIANTHUS THERAPEUTICS INC | $12.2M | 1.71% | -476,860 | -76.6% |
| 16 | AXSM | AXSOME THERAPEUTICS INC. | $10.5M | 1.47% | -139,511 | -69.2% |
| 17 | DFTX | DEFINIUM THERAPEUTICS INC | $7.0M | 0.98% | +369,588 | NEW |
| 18 | DHR | DANAHER CORPORATION | — | — | -346,875 | EXITED |
| 19 | BSX | BOSTON SCIENTIFIC CORP | — | — | -520,508 | EXITED |
| 20 | IONS | IONIS PHARMACEUTICALS INC | — | — | -557,174 | EXITED |
| 21 | VERA | VERA THERAPEUTICS INC | — | — | -805,689 | EXITED |
Source: SEC EDGAR · accession 0001826434-26-000004. 13F discloses long positions only — shorts, foreign equities, and options are excluded.